Displaying 1 - 12 of 31
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Liver Tumours
6

Bayer: Advancements in MRI for imaging assessment of HCC:  Practical considerations for differential diagnosis of focal liver lesions - EASL Liver Cancer Summit 2023

View
Cirrhosis & Complications
6

Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019

View
Cirrhosis & Complications
6

Shionogi: Procedural risk of bleeding – does the management of TCP in CLD patients make a difference? A debate - The International Liver Congress™ 2019

View